Pharmaniaga Berhad (KLSE:PHARMA)

Market Cap	367.51M
Revenue (ttm)	3.62B
Net Income (ttm)	94.05M
Shares Out	1.44B
EPS (ttm)	0.07
PE Ratio	3.91
Forward PE	7.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,648,700
Average Volume	1,880,430
Open	0.285
Previous Close	0.280
Day's Range	0.255 - 0.285
52-Week Range	0.255 - 0.470
Beta	1.45
RSI	16.11
Earnings Date	Feb 28, 2025

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; ove...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1994
• Employees: 3,476
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: PHARMA

Financial Performance

In 2023, Pharmaniaga Berhad's revenue was 3.40 billion, a decrease of -2.20% compared to the previous year's 3.48 billion. Losses were -80.16 million, -87.27% less than in 2022.